Systemic sclerosis. A vascular perspective (Q40922429)

24 September 2017

1 reference

title

Systemic sclerosis. A vascular perspective (English)

1 reference

24 September 2017

LeRoy EC

1

1 reference

24 September 2017

1 November 1996

1 reference

Rheumatic Diseases Clinics of North America

24 September 2017

1 reference

24 September 2017

22

1 reference

24 September 2017

4

1 reference

24 September 2017

675-694

1 reference

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

HLA and autoimmunity in scleroderma (systemic sclerosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

The role of the trimolecular complex (alpha beta TCR-MHC+peptide) in the pathogenesis of systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Mast cells: accessory cells which potentiate fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Retroviruses and the pathogenesis of systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

The vascular endothelium in scleroderma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Endothelial injury in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Regulation of type I collagen genes expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Adhesion molecules in scleroderma: collagen binding integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Molecular structure and function of autoantigens in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Erectile dysfunction in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Transforming growth factor-beta: latent forms, binding proteins and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Endothelial receptor tyrosine kinases involved in angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Role of T cells and cytokines in effecting fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Interstitial lung disease of systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Regulation of connective tissue synthesis in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Raynaud's phenomenon together with antinuclear antibodies: a common subset of incomplete connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Autoantibodies in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Animal models of scleroderma: contrasts and comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

T cell repertoire in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970295-7

7 January 2021

10.1016/S0889-857X(05)70295-7

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8923590